Robert Malone, Editor of Inbound Logistics magazine, recently commented that, “it doesn’t take a rocket scientist to discover that pharmaceuticals are a prime candidate for the use of RFID in our new era of high security.”
In recent months, there have been significant developments in the pharmaceutical marketspace, as both Pfizer and Purdue Pharma have announced significant RFID-labeling programs for two of their most sought after – both legally and illegally – drug products. Pfizer has announced that by the end of the first quarter of 2006, all shipments of Viagra, the lifestyle drug for erectile dysfunction, will carry RFID tags. Likewise, the privately-held Purdue Pharma has green-lighted a significant pilot program to apply smart labels to all shipments of OxyContin, a narcotic pain-killer.
There are 1019 words in the rest of this article …
Library Access Required
Library subscribers have access to the full archives of more than 10,000 original news items and feature articles published by AVISIAN’s suite of ID technology publications (ContactlessNews.com, CR80News.com, DigitalIDNews.com, FIPS201.com, NFCNews.com, RFIDNews.org, SecureIDNews.com, and ThirdFactor.com).
For just $49, you receive unlimited password-protected access to content on all of AVISIAN’s sites for an entire year. Your subscription helps fund the continued creation of independent, insightful content. Find out more.
Sign in as a Subscriber
If you are already a subscriber, you may sign in now. Enter your Email Address and Password and click Sign In.
If you have forgotten your password, enter just your Email Address, and click Send Password.
